Raymond James adds James Kim to Health Care Investment Banking

ST. PETERSBURG, Fla. – Raymond James has hired experienced finance professional James Kim as managing director in the firm’s Health Care Investment Banking practice. Based in New York City, Kim will focus on the life sciences and biotechnology sectors.

“James is a talented banker with deep expertise in the biotech sector,” said Jim Bunn, president of Raymond James Global Equities and Investment Banking. “As we continue to grow the life sciences presence across our global banking platform, our focus is on attracting top-quality talent who are adept at delivering results to clients, and we’re pleased to add James to our respected group.”

Kim joins Raymond James from Cantor Fitzgerald where he spent the past three years as managing director in the health care investment banking group. Prior to Cantor Fitzgerald, Kim served as managing director of health care investment banking at Jefferies and worked at UBS in their health care investment banking group. He has more than 16 years of experience working with and advising clients in the life sciences and biopharmaceutical sectors. Kim graduated from The Wharton School of the University of Pennsylvania with a degree in economics.

“As biotech continues to disrupt the healthcare sector and grow in importance to the overall market, our clients require and appreciate counsel from experienced professionals with access to an industry-leading distribution platform,” said Andrew Gitkin, co-head of Health Care Investment Banking. “James’ ability to understand and blend both the science and finance sides of the sector is a real differentiator to clients and we’re thrilled to have him join our team.”

About Raymond James Investment Banking

Raymond James Investment Banking offers highly regarded capital formation and financial advisory services. Since 2015, we have participated in raising nearly $220 billion in capital for our corporate clients and completed more than 720 advisory assignments, including more than 610 M&A buy-side or sell-side advisory assignments.

About Raymond James Financial, Inc.

Raymond James Financial, Inc. (NYSE: RJF) is a leading diversified financial services company providing private client group, capital markets, asset management, banking and other services to individuals, corporations and municipalities. The company has approximately 8,000 financial advisors. Total client assets are $838 billion. Public since 1983, the firm is listed on the New York Stock Exchange under the symbol RJF. Additional information is available at www.raymondjames.com. Raymond James & Associates, Inc., member New York Stock Exchange/SIPC.